Rinsho Ketsueki
Online ISSN : 1882-0824
Print ISSN : 0485-1439
ISSN-L : 0485-1439
Case Reports
Successful treatment with rituximab in two cases of IgM-monoclonal gammopathy of undetermined significance (MGUS) neuropathy
Michiaki KOIKEKeiji SUGIMOTOMiyuki TUSUIYuriko YAHATA
Author information
JOURNAL RESTRICTED ACCESS

2012 Volume 53 Issue 4 Pages 450-454

Details
Abstract
A 66-year-old male was hospitalized with muscle weakness and gait disturbance. Examination revealed IgM 3,407mg/dl (IgM, κ-type M protein) and he was diagnosed as having IgM-MGUS neuropathy. He suffered from paralysis of respiratory muscles and required a respirator support. Plasmapheresis and intravenous immunoglobulin were performed and he was weaned from the respirator. Rituximab given as 8 weekly infusions improved gait disturbance. A 71-year-old male was hospitalized with lumbago, numbness of lower extremities and gait disturbance. Examination revealed IgM 1,553 mg/dl (IgM, λ-type M protein) and he was diagnosed with IgM-MGUS neuropathy. Rituximab given as 8 weekly infusions improved gait disturbance. It was concluded that rituximab is a well-tolerated treatment that may be effective in some patients with IgM-MGUS neuropathy.
Content from these authors
© 2012 The Japanese Society of Hematology
Previous article Next article
feedback
Top